Wednesday, March 27, 2024 1:49:30 PM
So now, FORW (Sharp) hired lawyers and filed a complaint. HMBL got their lawyers involved. Adversarial relationship at this point. You contend that Foote just gave Sharp his money back because the stock tanked. Yet in a lawsuit, you need to specify a cause of action - someone must have done some thing legally unacceptable. Stock falling is not a legal cause of action. BUT, breach of fiduciary duty is. As is breach of contract. Especially if something like toxic debt was discussed as part of the resignation AND the rehire of Sharp. It was likely brought up when FORW paid $2mil to exercise those warrants with certain assurances.
If Sharp quit because of things like toxic debt, it wouldn't make sense for him to come back without certain assurances. If he were to invest (provide $2mil in funding) in HMBL, he would logically need those assurances.
But yea, maybe the lawyers for HMBL have no clue that "my stock went down so I can sue you" is not an adequate cause of action. Cmon... you are just baiting me to call you names again.
Recent HMBL News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 02:19:41 PM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 01/03/2024 05:00:32 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 12/06/2023 09:05:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/25/2023 01:00:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/13/2023 09:20:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/31/2023 01:15:12 PM
- Form 1-A - Offering Statement [Regulation A] • Edgar (US Regulatory) • 08/22/2023 07:48:47 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 09:14:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/04/2023 08:53:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/20/2023 09:15:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/20/2023 09:15:09 PM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 06/30/2023 08:35:16 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM